| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.28 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |